Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow

被引：0
作者：
T S Larsen
N Pallisgaard
M B Møller
H C Hasselbalch
机构：
[1] Odense University Hospital,Department of Haematology
[2] Odense University Hospital,Department of Pathology
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：194 / 195
页数：1
相关论文
共 33 条
  • [1] James C(2005)A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 1144-1148
  • [2] Ugo V(2005)Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 1054-1061
  • [3] Le Couedic JP(2007)Detecting the JAK2 V617F mutation in fresh and ‘historic’ blood and bone marrow Leukemia 21 1559-1662
  • [4] Staerk J(2006)The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera Cancer 106 631-635
  • [5] Delhommeau F(2006)A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis Leukemia 20 1055-1060
  • [6] Lacout C(2007)The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders Br J Haematol 136 745-751
  • [7] Baxter EJ(undefined)undefined undefined undefined undefined-undefined
  • [8] Scott LM(undefined)undefined undefined undefined undefined-undefined
  • [9] Campbell PJ(undefined)undefined undefined undefined undefined-undefined
  • [10] East C(undefined)undefined undefined undefined undefined-undefined
1234